Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,643
  • Shares Outstanding, K 26,318
  • Annual Sales, $ 49,240 K
  • Annual Income, $ -27,450 K
  • 60-Month Beta 2.49
  • Price/Sales 2.60
  • Price/Cash Flow N/A
  • Price/Book 1.32
Trade STIM with:

Options Overview Details

View History
  • Implied Volatility 115.10%
  • Historical Volatility 110.63%
  • IV Percentile 88%
  • IV Rank 42.91%
  • IV High 161.03% on 11/02/20
  • IV Low 80.58% on 08/04/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 181
  • Volume Avg (30-Day) 151
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 657
  • Open Int (30-Day) 240

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.28
  • Number of Estimates 2
  • High Estimate -0.27
  • Low Estimate -0.28
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.62 +13.20%
on 10/14/21
6.84 -23.54%
on 09/24/21
-1.21 (-18.79%)
since 09/17/21
3-Month
4.62 +13.20%
on 10/14/21
14.50 -63.93%
on 07/22/21
-8.17 (-60.97%)
since 07/19/21
52-Week
4.62 +13.20%
on 10/14/21
22.43 -76.68%
on 01/22/21
-0.80 (-13.27%)
since 10/19/20

Most Recent Stories

More News
CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, October 12th from Neuronetics, Inc. (NASDAQ:...

STIM : 5.23 (+3.77%)
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...

STIM : 5.23 (+3.77%)
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector

/PRNewswire/ -- A massive disruption now appears imminent in one of the world's largest – and most important – industries. In much the same way that Amazon...

SAGE : 40.29 (-8.58%)
SAVA : 47.50 (-5.30%)
STIM : 5.23 (+3.77%)
CMPS : 33.78 (+6.83%)
ACHC : 56.76 (+0.41%)
The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Neuronetics, Inc. (“Neuronetics” or the “Company”) (NASDAQ: STIM ) on behalf of investors concerning the Company’s possible violations...

STIM : 5.23 (+3.77%)
Neuronetics Announces Preliminary Revenue for Third Quarter 2021

MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing,...

STIM : 5.23 (+3.77%)
Neuronetics Announces Commercial Agreement with Success TMS

MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing,...

STIM : 5.23 (+3.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 5.57
2nd Resistance Point 5.40
1st Resistance Point 5.31
Last Price 5.23
1st Support Level 5.06
2nd Support Level 4.89
3rd Support Level 4.81

See More

52-Week High 22.43
Fibonacci 61.8% 15.63
Fibonacci 50% 13.52
Fibonacci 38.2% 11.42
Last Price 5.23
52-Week Low 4.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar